Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. DPZ
6. PRIM
7. META
8. IMNN
9. NAVN
10. NVDA

Go back to Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy

Solid Biosciences (SLDB) Climbs 26% Following Pact with Ultragenyx Pharma (RARE) in DMD

October 23, 2020 8:18 AM EDT

Solid Biosciences (NASDAQ: SLDB) Climbs 26% Following Pact with Ultragenyx Pharma (NASDAQ: RARE) in DMD

Earlier Ultragenyx, Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for DMD... More